imipramine has been researched along with Hypertrophy, Left Ventricular in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, K | 1 |
| Ratner, M | 1 |
| Stoll, M | 1 |
1 other study available for imipramine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Pheochromocytoma unmasked by imipramine in an 8-year-old girl.
Topics: Catecholamines; Child; Emergencies; Enuresis; Female; Heart Murmurs; Humans; Hypertension; Hypertrop | 2003 |